Diclofenac/menthol

Drug Profile

Diclofenac/menthol

Alternative Names: Diclofenac-menthol; Menthol/diclofenac; MFC 51123

Latest Information Update: 11 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Class Cyclohexanols; Monoterpenes; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 11 Apr 2017 Discontinued - Phase-I for Pain (In volunteers) in USA (Topical), because not listed on GSK pipeline, April 2017
  • 11 Apr 2017 Discontinued - Phase-III for Pain in Germany (Topical), because not listed on GSK pipeline, April 2017
  • 01 Mar 2015 GlaxoSmithKline completes a phase III trial in Pain in Germany (NCT02100670)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top